Abstract
Use of Paclitaxel Associated to Lipid Core Nanoparticles (LDE) in the Second or Third Line Treatment of Advanced Pancreatic Adenocarcinoma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have